Skip to main content
logo
NexgenRx Inc. (TSXV:NXG)
Canada flag Canada · Delayed Price · Currency is CAD
0.4250
+0.0050 (1.19%)
At close: Nov 28, 2025

NexgenRx Revenue

NexgenRx had revenue of 4.62M CAD in the quarter ending September 30, 2025, with 13.43% growth. This brings the company's revenue in the last twelve months to 17.71M, up 11.77% year-over-year. In the year 2024, NexgenRx had annual revenue of 16.48M with 18.99% growth.

Revenue (ttm)
17.71M
Revenue Growth
+11.77%
P/S Ratio
1.71
Revenue / Employee
885.68K
Employees
20
Market Cap
30.22M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202416.48M2.63M18.99%
Dec 31, 202313.85M1.07M8.33%
Dec 31, 202212.78M939.94K7.94%
Dec 31, 202111.84M1.27M12.01%
Dec 31, 202010.57M1.03M10.82%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Curaleaf Holdings1.78B
dentalcorp Holdings1.66B
Trulieve Cannabis1.66B
Green Thumb Industries1.61B
Extendicare1.59B
WELL Health Technologies1.25B
Sienna Senior Living967.05M
Knight Therapeutics413.85M
Revenue Rankings

NexgenRx News

More News